Joydeep Das
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Joydeep Das has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Mousumi Kundu
Division of Molecular Medicine, Bose Institute, P-1/12, CIT Scheme VII M, Kolkata 700054, India
3 shared publications- Parames Chandra Sil
Division of Molecular Medicine, Bose Institute, Kolkata, India
3 shared publications Abhishek Kumar Das
Division of Molecular Medicine, Bose Institute, P-1/12, CIT Scheme VII M, Kolkata 700054, India
2 shared publicationsNeelam Thakur
School of Advance Chemical Sciences, Shoolini University, Solan, 173229, India
2 shared publicationsNoyel Ghosh
Division of Molecular Medicine, Bose Institute, P-1/12, CIT Scheme VII M, Kolkata 700054, India
2 shared publicationsSamhita De
Division of Molecular Medicine, Bose Institute, P-1/12, CIT Scheme VII M, Kolkata 700054, India
2 shared publications
Latest Publications
- Open Access
Chitosan-PEI passivated carbon dots for plasmid DNA and miRNA-153 delivery in cancer cells
- 28 December 2022
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 631, 122555
pH-responsive and targeted delivery of chrysin via folic acid-functionalized mesoporous silica nanocarrier for breast cancer therapy
- 28 December 2022
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 631, 122555
pH-responsive and targeted delivery of chrysin via folic acid-functionalized mesoporous silica nanocarrier for breast cancer therapy
- 19 August 2022
- Published by Springer Nature in Journal of Nanoparticle Research
- Vol. 24 (9) , 1-20
Morin-loaded nanoceria as an efficient nanoformulation for increased antioxidant and antibacterial efficacy
- 19 August 2022
- Published by Springer Nature in Journal of Nanoparticle Research
- Vol. 24 (9) , 1-20
Morin-loaded nanoceria as an efficient nanoformulation for increased antioxidant and antibacterial efficacy
- Open Access
Expression of GRINA Correlates with Prognosis in Human Cancers: A Pan-cancer Analysis
GRINA is an emerging target for cancer therapy. However, the role of GRINA expression and its correlation with cancer patient survival has not been comprehensively studied. Here, we found that mRNA and protein expression of GRINA was upregulated in breast, colon, gastric, and prostate cancers and negatively correlated with patient survival. Also, the upregulation of GRINA expression is associated with hypomethylation of its promoter region. Our GRINA-miRNAs network analysis revealed potential regulatory miRNAs regulating the GRINA expression and its downstream pathways. Next, functional enrichment and pathway analysis of genes commonly co-express with GRINA in breast, colon, gastric, and prostate cancers revealed GRINA regulatory pathways. Concurrently, our upstream regulator analysis revealed possible kinases, transcription factors, and proteins that may potentially regulate GRINA . Overall, this study demonstrates the prognostic significance of GRINA expression and identifies potential regulatory mechanisms, which might have significant implications in targeted therapies for human cancers.
Open AccessExpression of GRINA Correlates with Prognosis in Human Cancers: A Pan-cancer Analysis
GRINA is an emerging target for cancer therapy. However, the role of GRINA expression and its correlation with cancer patient survival has not been comprehensively studied. Here, we found that mRNA and protein expression of GRINA was upregulated in breast, colon, gastric, and prostate cancers and negatively correlated with patient survival. Also, the upregulation of GRINA expression is associated with hypomethylation of its promoter region. Our GRINA-miRNAs network analysis revealed potential regulatory miRNAs regulating the GRINA expression and its downstream pathways. Next, functional enrichment and pathway analysis of genes commonly co-express with GRINA in breast, colon, gastric, and prostate cancers revealed GRINA regulatory pathways. Concurrently, our upstream regulator analysis revealed possible kinases, transcription factors, and proteins that may potentially regulate GRINA . Overall, this study demonstrates the prognostic significance of GRINA expression and identifies potential regulatory mechanisms, which might have significant implications in targeted therapies for human cancers.